[{"data": {"name": "Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "T. Coelho", "@type": "Person"}, {"name": "L. F. Maia", "@type": "Person"}, {"name": "A. Martins da Silva", "@type": "Person"}, {"name": "M. Waddington Cruz", "@type": "Person"}, {"name": "V. Plante-Bordeneuve", "@type": "Person"}, {"name": "P. Lozeron", "@type": "Person"}, {"name": "O. B. Suhr", "@type": "Person"}, {"name": "J. M. Campistol", "@type": "Person"}, {"name": "I. M. Conceicao", "@type": "Person"}, {"name": "H. H.- J. Schmidt", "@type": "Person"}, {"name": "P. Trigo", "@type": "Person"}, {"name": "J. W. Kelly", "@type": "Person"}, {"name": "R. Labaudiniere", "@type": "Person"}, {"name": "J. Chan", "@type": "Person"}, {"name": "J. Packman", "@type": "Person"}, {"name": "A. Wilson", "@type": "Person"}, {"name": "D. R. Grogan", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4098875?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Ovid Technologies (Wolters Kluwer Health)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1212/wnl.0b013e3182661eb1", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCfWvcjvM1Zre-CTXsjDzFE6fz1-CDj98jwN4grfs-CRvyAfxyiHQET", "propertyID": "ISCC"}], "datePublished": "2012-07-25"}, "schema": "schema.org", "mediatype": "application/ld+json"}]